COVID-19 Vaccine Responsiveness in Patients with Multiple Myeloma and Waldenström Macroglobulinemia

BACKGROUND: Multiple myeloma (MM) and Waldenström macroglobulinemia (WM) are associated with significant immunoparesis. Based on the ongoing COVID-19 pandemic, there is an urgent need to understand whether patients are able to mount a sufficient response to COVID-19 vaccines. METHODS: MM and WM pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Branagan, Andrew R., Lei, Matthew M, Maron, Jenny S, Yee, Andrew J, O'Donnell, Elizabeth, Castillo, Jorge J., Raje, Noopur S., Treon, Steven P, Flynn, Catherine A, Mo, Clifton C., Nadeem, Omar, Richardson, Paul G., Panaroni, Cristina, Meid, Kirsten, Bernstein, Zachary S., Lyons, Rebecca T., Hunter, Zachary R, Guerrera, Maria Luisa, Gammon, Marilyn T., Lively, Kathleen J., Packer, Lisette, Waterman, Matthew, Gallagher, Raquel, Juleg, Boris, Alter, Galit, Sarosiek, Shayna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701550/
http://dx.doi.org/10.1182/blood-2021-154089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701550/
http://dx.doi.org/10.1182/blood-2021-154089

Ejemplares similares